Skip to content
Open access

Evaluating Systematic and Proportional Bias in Point-of-care Glucose Testing: A Correlation and Bland-Altman Analysis

Aug 2026 · Apollo Medicine · 0 citations · 20 references

TL;DR

POCT glucose measurements show excellent correlation with laboratory auto-analyser results but exhibit systematic and proportional bias, particularly at higher glucose levels, particularly at higher glucose levels.

Abstract

Point-of-care testing (POCT) for blood glucose provides rapid results and is widely used in clinical practice; however, concerns remain regarding its accuracy and agreement with laboratory auto-analyser methods. The purpose of this study was to compare glucose measurements obtained using POCT and a laboratory auto-analyser in a secondary healthcare centre within a low-resource setting. A comparison study was conducted using 120 paired blood glucose measurements obtained simultaneously by a POCT glucometer and a laboratory auto-analyser. Descriptive statistics were used to summarise glucose values. Pearson correlation and linear regression analyses assessed the relationship between methods, while agreement was evaluated using Bland-Altman analysis. Statistical significance was set at P < .05. The mean glucose concentration measured by POCT was 6.59 ± 2.27 mmol/L, while that measured by the auto-analyser was 6.33 ± 2.93 mmol/L. A strong positive correlation was observed between the two methods ( r = 0.971, P < .001). Linear regression analysis yielded the equation auto-analyser = 1.249 × POCT − 1.905 ( R ² = 0.943), indicating proportional bias. Bland-Altman analysis demonstrated a mean bias of −0.26 mmol/L, with 95% limits of agreement ranging from −2.03 to +1.50 mmol/L. Greater variability in differences was observed at higher glucose concentrations. POCT glucose measurements show excellent correlation with laboratory auto-analyser results but exhibit systematic and proportional bias, particularly at higher glucose levels. While POCT is suitable for rapid glucose assessment and monitoring, laboratory auto-analyser methods remain the preferred reference for diagnostic and critical clinical decision-making.

Read PDF

Similar papers

Open access Aug 2026

Cross-sectional evaluation of two point-of-care glucose meters against the GOD-PAP reference method

Both POCT devices demonstrated acceptable analytical agreement with the GOD-PAP method for blood glucose testing, however, Emtech BG Max 1 exhibited superior precision, lower analytical bias, and higher compliance with ISO 15197:2013, indicating greater reliability for routine clinical use.

Muhammad Jalil Razak, N. Ismi, Marisca Jenice Sanakya et al. · 0 citations
Open access 2026

CORRELATION BETWEEN POINT-OF-CARE AND LABORATORY-BASED AUTOMATED BLOOD GLUCOSE TESTING

It is indicated that glucometers tend to overestimate glucose levels, consistent with previous studies, and laboratory autoanalyzers remain the gold standard for accurate glucose estimation.

Vaaruni Sharma, Ajay K. Puri · 0 citations
Open access Aug 2026

Validation of Precision and Accuracy of Point-of-Care Testing Glucose Analyzers with a Standard Laboratory Method (Glucose Oxidase Method)

POCT glucose meters should be used cautiously and primarily for monitoring trends rather than definitive diagnosis or therapeutic decisions, as they have limited reliability for critical clinical decision-making.

E. Nwobodo, N. T. Emmanuel · 0 citations
Open access 2026

Evaluation of the accuracy of a portable glucose meter compared with laboratory-based spectrophotometric methods

The glucometer demonstrated moderate performance and partial agreement with selected ISO 15197:2015 accuracy limits compared with laboratory-based spectrophotometric methods, but increased variability at higher glucose concentrations limits its applicability in settings requiring high analytical precision.

Pablo Letelier, Guido Fierro, K. Cuminao et al. · 0 citations
Open access Jan 2026

Blood Glucose Monitoring in the Neonatal Period: A Study on Evaluation Using the RAPIDPoint 500/500e.

Blood gas analyzers provide clinically useful glucose measurements in newborns, however, discrepancies from central laboratory measurements may occur under certain physiological conditions, and confirmatory testing remains essential when severe hypoglycemia is suspected.

I. Kurosawa, Hiroshi Miyabayashi, Yasue Goko et al. · 0 citations
Open access Aug 2026

Validation of point-of-care INR testing against standard laboratory methods in a Malaysian primary healthcare setting

The study concludes that the Wondfo POCT device demonstrates acceptable agreement with standard laboratory testing within therapeutic ranges, thereby offering a viable alternative for rapid, decentralized INR monitoring, particularly in outpatient care, and can potentially improve patient management and safety.

Rosline Hassan, S. Iberahim, S. S. Mohd Yusoff et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.